Your session is about to expire
← Back to Search
Smoking Cessation Intervention for HIV/AIDS
Study Summary
This trial tests a smartphone app that may help HIV+ people quit smoking. Positively Smoke Free - Mobile could be a useful smoking cessation tool.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have not had pneumonia or a serious lung infection in the last 3 months.I am on HIV medication and my CD4 count is at least 200.I cannot use nicotine replacement therapy due to health reasons.You have recently tried to quit smoking or are currently using other methods to help you quit smoking.I own a smartphone compatible with the PSF-M app.I am between 45 and 80 years old.I have had lung cancer in the past.I am between 45-80 years old and have a history of heavy smoking.I don't have any major illnesses or situations that would stop me from following the study's requirements.I am HIV positive.
- Group 1: Prevention (smoking cessation, nicotine replacement, LDCT)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are individuals past the age of fifty being incorporated into this clinical research?
"This trial is only available for participants aged 45 to 80. There are 151 trials offering assistance to those below 18 years of age and 503 clinical studies accommodating patients over 65."
Is there a precedent for using preventive measures such as smoking cessation, nicotine replacement and LDCT in clinical studies?
"At the moment, 3 Phase 3 trials for Prevention (smoking cessation, nicotine replacement, LDCT) are actively being conducted. While most of these studies are centered in Fridley, Minnesota there exist 195 distinct research sites operating clinical trials concerning prevention and smoking suppression initiatives."
How many individuals are currently participating in this research study?
"This clinical trial's recruitment period has closed; it was initially uploaded on April 15th 2023 and last revised by researchers on March 10th. If you're seeking to participate in other trials, 618 studies related to HIV/AIDS require participants while 65 investigations focusing on smoking cessation, nicotine replacement therapy, or low-dose computed tomography are currently looking for volunteers."
Are there still vacancies available for participants in this investigative trial?
"According to the clinicaltrials.gov database, this experiment is not actively recruiting at this time as it was last edited on March 10th 2023. Although there are no more openings for this trial, 683 other medical studies remain open to new participants."
Share this study with friends
Copy Link
Messenger